CN109646315B - Oral composition, method for producing same, and method for inhibiting yellowing of oral composition - Google Patents
Oral composition, method for producing same, and method for inhibiting yellowing of oral composition Download PDFInfo
- Publication number
- CN109646315B CN109646315B CN201811182360.2A CN201811182360A CN109646315B CN 109646315 B CN109646315 B CN 109646315B CN 201811182360 A CN201811182360 A CN 201811182360A CN 109646315 B CN109646315 B CN 109646315B
- Authority
- CN
- China
- Prior art keywords
- component
- oral composition
- mass
- titanium oxide
- yellowing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 85
- 238000004383 yellowing Methods 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title claims abstract description 16
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 36
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 35
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 32
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 27
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims abstract description 25
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000004006 olive oil Substances 0.000 claims abstract description 18
- 235000008390 olive oil Nutrition 0.000 claims abstract description 18
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 13
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 13
- 235000019437 butane-1,3-diol Nutrition 0.000 claims abstract description 12
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 11
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims abstract description 11
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000000600 sorbitol Substances 0.000 claims abstract description 11
- 239000004615 ingredient Substances 0.000 claims description 5
- 239000003921 oil Substances 0.000 claims description 5
- 235000019198 oils Nutrition 0.000 claims description 5
- 239000000551 dentifrice Substances 0.000 claims description 4
- 238000004378 air conditioning Methods 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims 3
- 239000000811 xylitol Substances 0.000 claims 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims 3
- 229960002675 xylitol Drugs 0.000 claims 3
- 235000010447 xylitol Nutrition 0.000 claims 3
- 239000000377 silicon dioxide Substances 0.000 abstract description 6
- 235000012239 silicon dioxide Nutrition 0.000 abstract 1
- -1 fatty acid esters Chemical class 0.000 description 20
- 238000009472 formulation Methods 0.000 description 11
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 235000013772 propylene glycol Nutrition 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 239000003899 bactericide agent Substances 0.000 description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 239000006072 paste Substances 0.000 description 5
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 235000010215 titanium dioxide Nutrition 0.000 description 3
- 239000000606 toothpaste Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- SVIJYLPSHPPVQF-UHFFFAOYSA-N 2-[2,2-diaminoethyl(dodecyl)amino]acetic acid Chemical compound CCCCCCCCCCCCN(CC(N)N)CC(O)=O SVIJYLPSHPPVQF-UHFFFAOYSA-N 0.000 description 2
- AXCXHFKZHDEKTP-NSCUHMNNSA-N 4-methoxycinnamaldehyde Chemical compound COC1=CC=C(\C=C\C=O)C=C1 AXCXHFKZHDEKTP-NSCUHMNNSA-N 0.000 description 2
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 239000001329 FEMA 3811 Substances 0.000 description 2
- 229920002148 Gellan gum Polymers 0.000 description 2
- 229920000569 Gum karaya Polymers 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 2
- XCOJIVIDDFTHGB-UEUZTHOGSA-N Perillartine Chemical compound CC(=C)[C@H]1CCC(\C=N\O)=CC1 XCOJIVIDDFTHGB-UEUZTHOGSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000934878 Sterculia Species 0.000 description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 235000010358 acesulfame potassium Nutrition 0.000 description 2
- 229960004998 acesulfame potassium Drugs 0.000 description 2
- 239000000619 acesulfame-K Substances 0.000 description 2
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 239000000305 astragalus gummifer gum Substances 0.000 description 2
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- 229960001950 benzethonium chloride Drugs 0.000 description 2
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 235000010492 gellan gum Nutrition 0.000 description 2
- 239000000216 gellan gum Substances 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 235000010494 karaya gum Nutrition 0.000 description 2
- 239000000231 karaya gum Substances 0.000 description 2
- 229940039371 karaya gum Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 2
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 2
- 235000010434 neohesperidine DC Nutrition 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 229940013618 stevioside Drugs 0.000 description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 2
- 235000019202 steviosides Nutrition 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000892 thaumatin Substances 0.000 description 2
- 235000010436 thaumatin Nutrition 0.000 description 2
- GQUJEMVIKWQAEH-UHFFFAOYSA-N titanium(III) oxide Chemical compound O=[Ti]O[Ti]=O GQUJEMVIKWQAEH-UHFFFAOYSA-N 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 229930007845 β-thujaplicin Natural products 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- WAUOTJNSQGJSSL-UQKRIMTDSA-N [(2s)-2-(methylamino)propanoyl] dodecanoate;sodium Chemical compound [Na].CCCCCCCCCCCC(=O)OC(=O)[C@H](C)NC WAUOTJNSQGJSSL-UQKRIMTDSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229940099418 d- alpha-tocopherol succinate Drugs 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229960001269 glycine hydrochloride Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- DCYOBGZUOMKFPA-UHFFFAOYSA-N iron(2+);iron(3+);octadecacyanide Chemical compound [Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] DCYOBGZUOMKFPA-UHFFFAOYSA-N 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- AXCXHFKZHDEKTP-UHFFFAOYSA-N para-methoxycinnamaldehyde Natural products COC1=CC=C(C=CC=O)C=C1 AXCXHFKZHDEKTP-UHFFFAOYSA-N 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 229960003351 prussian blue Drugs 0.000 description 1
- 239000013225 prussian blue Substances 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 239000010464 refined olive oil Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 238000000790 scattering method Methods 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229960000414 sodium fluoride Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- SLBXZQMMERXQAL-UHFFFAOYSA-M sodium;1-dodecoxy-4-hydroxy-1,4-dioxobutane-2-sulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O SLBXZQMMERXQAL-UHFFFAOYSA-M 0.000 description 1
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
The present invention provides an oral composition, a method for producing the same, and a method for inhibiting yellowing of the oral composition, wherein the oral composition contains olive oil in addition to silicon dioxide and titanium oxide, and the yellowing with time is inhibited. An oral composition comprising: (A) silica particles; (B) titanium oxide; (C) olive oil; and (D) at least one selected from the group consisting of polyethylene glycol, propylene glycol, 1, 3-butanediol, glycerol, diglycerol and sorbitol, and the mass ratio of the component (D) to the component (C) is 1:6 or less.
Description
Technical Field
The present invention relates to an oral composition, a method for producing the same, a method for inhibiting yellowing of the oral composition, and the like.
Background
The oral composition is a composition suitable for use in the oral cavity, and therefore, when selected by a consumer, the color or the stability of the color over time becomes an important factor. For example, patent document 1 describes the following: an oral composition which suppresses changes in coloration with time is prepared by blending a specific flavor and a specific sugar.
Prior art literature
Patent literature
Patent document 1 japanese patent laid-open publication No. 2013-170143
Disclosure of Invention
Problems to be solved by the invention
In addition, in the development of oral compositions, it has been studied to formulate various ingredients according to the needs of consumers. As an example, it is considered to prepare a moisturizing component (e.g., a humectant) for the purpose of keeping the mouth moist, improving the mouth feel, or the like.
The inventors of the present invention studied the blending of olive oil as a wetting ingredient in an oral composition. As a result, it was found that when olive oil was further blended into an oral composition containing silica and titanium oxide, yellowing of the appearance occurred with time (particularly by irradiation of light). In the oral composition, silica is a component frequently used as an abrasive, and titanium oxide is a component frequently used to make the composition beautiful in color. Therefore, if it is difficult to further blend the olive oil when these ingredients are contained, there is a concern that not only product development is hindered, but also it is difficult to provide an oral composition having preferable properties to consumers.
Accordingly, an object of the present invention is to provide an oral composition which contains olive oil in addition to silica and titanium oxide and which is suppressed in yellowing with time.
Technical means for solving the problems
The present inventors have found that the yellowing can be suppressed by further formulating a specific polyol, and further repeatedly improved, and completed the present invention.
The present invention includes, for example, the subject matter described below.
Item 1.
An oral composition comprising:
(A) Silica particles;
(B) Titanium oxide;
(C) Olive oil; a kind of electronic device with high-pressure air-conditioning system
(D) At least one selected from the group consisting of polyethylene glycol, propylene glycol, 1, 3-butanediol, glycerol, diglycerol and sorbitol, and
(D) The mass ratio of the component (C) to the component (C) is 1:6 or less.
Item 2.
The oral composition according to item 1, wherein the mass ratio of the (B) component to the (C) component is 1:0.01 to 1:10.
item 3.
The oral composition of item 1 or 2, which is a dentifrice composition.
Item 4a.
A method of inhibiting yellowing of an oral composition, the method comprising: a step of blending (D) at least one selected from the group consisting of polyethylene glycol, propylene glycol, 1, 3-butanediol, glycerol, diglycerol and sorbitol, and
the oral composition contains (A) silica particles, (B) titanium oxide, and (C) olive oil.
Item 4b.
A method for inhibiting yellowing of an oral composition comprising (A) silica particles, (B) titanium oxide, and (C) olive oil
The method comprises the following steps: the mass ratio of the component (D) to the component (C) is 1:6 (D) at least one step selected from the group consisting of polyethylene glycol, propylene glycol, 1, 3-butanediol, glycerol, diglycerol and sorbitol.
Item 5a.
A method of manufacturing an oral composition comprising: a step of blending (D) at least one selected from the group consisting of polyethylene glycol, propylene glycol, 1, 3-butanediol, glycerol, diglycerol and sorbitol, and
the oral composition contains (A) silica particles, (B) titanium oxide, and (C) olive oil, and yellowing is suppressed.
Item 5b.
A method for producing an oral composition which comprises (A) silica particles, (B) titanium oxide, and (C) olive oil, and which is suppressed in yellowing,
the method comprises the following steps: the mass ratio of the component (D) to the component (C) is 1:6 (D) at least one step selected from the group consisting of polyethylene glycol, propylene glycol, 1, 3-butanediol, glycerol, diglycerol and sorbitol.
ADVANTAGEOUS EFFECTS OF INVENTION
According to the present invention, there is provided an oral composition which contains olive oil in addition to silica and titanium oxide and which is suppressed in yellowing with time.
Detailed Description
Hereinafter, embodiments of the present invention will be described in further detail.
The oral composition of the present invention comprises: (A) silica particles; (B) titanium oxide; (C) olive oil; and (D) at least one selected from the group consisting of polyethylene glycol, propylene glycol, 1, 3-butanediol, glycerol, diglycerol, and sorbitol. In the present specification, these components may be referred to as "component (a)", "component (B)", "component (C)", and "component (D)", respectively.
As the silica particles (a), known silica particles used in oral compositions can be used. For example, the silica particles may be either abrasive silica particles or thickening silica particles, and abrasive silica particles are preferable. The method of producing the resin is not particularly limited. For example, precipitated silica particles are preferably exemplified. The particle size of the silica particles is not particularly limited, and silica particles having a usual particle size used in oral compositions can be used. For example, silica particles having an average particle diameter of about 1 μm to 20 μm, preferably about 2 μm to 15 μm, and more preferably about 2 μm to 10 μm are preferable.
The average particle diameter of silica in the present specification is d50, and is a value obtained by using water as a dispersion and using a laser diffraction scattering method. The value can be measured, for example, using a Markov particle analyzer (Malvern Mastersizer) using a low output He/Ne laser and utilizing the Fraunhofer diffraction principle.
As the titanium oxide (B), a known titanium oxide used in an oral composition can be used. As an embodiment thereof, for example, titanium oxide particles (powder) can be preferably used. The term "titanium oxide" is a generic term for titanium (II) oxide, titanium (III) oxide, titanium (IV) oxide, titanium dioxide, and one or a combination of two of the three kinds of titanium oxide may be used as the term "titanium oxide". In other words, the "titanium oxide" is at least one selected from the group consisting of titanium (II) oxide, titanium (III) oxide, and titanium (IV) oxide.
The olive oil (C) is not particularly limited, and an olive oil for eating or cosmetic use can be used. For example, virgin oil (virgin oil), extra virgin oil (extra virgin oil), refined olive oil, and the like can be used.
As the component (D), a specific polyol is used. Specifically, polyethylene glycol, propylene glycol, 1, 3-butanediol, glycerol, diglycerol, and sorbitol are mentioned. Among these components, divalent or trivalent alcohols (i.e., polyethylene glycol, propylene glycol, 1, 3-butanediol, and glycerin) are preferred. The average molecular weight of polyethylene glycol is not particularly limited, and is, for example, preferably about 100 to 10000, more preferably about 200 to 5000, and most preferably about 400 to 1000. These components may be used singly or in combination of two or more as the (D) component.
In the oral composition of the present invention, the mass ratio of the component (D) to the component (C) ((component (D)) is 1: below 6, preferably 1: less than 5, more preferably 1:4 or less, and further preferably 1:3 or less. The lower limit of the ratio of the component (C) in the mass ratio is not particularly limited, and may be, for example, 0.0001 or more, 0.0005 or more, 0.001 or more, 0.005 or more, or 0.01 or more. More specifically, the mass ratio of the component (D) to the component (C) may be, for example, 1:0.0001 to 1:6. 1:0.0005 to 1:6. 1:0.001 to 1:6. 1: 0.005-1: 6. or 1:0.01 to 1:6.
in the oral composition of the present invention, the component (D) is preferably contained in an amount of 5 to 50% by mass, more preferably 10 to 40% by mass.
The content of the component (C) is preferably 0.001 to 10% by mass, more preferably 0.005 to 8% by mass, and still more preferably 0.01 to 5% by mass.
In the oral composition of the present invention, the mass ratio of the component (B) to the component (C) (component (B) is preferably 1:0.01 to 1:20, more preferably 1:0.02 to 1:15.
the content of the component (a) in the oral composition of the present invention can be appropriately set. For example, about 1 to 50 mass%, 5 to 40 mass%, or 10 to 30 mass% can be exemplified.
In the oral composition of the present invention, the component (B) is preferably contained in an amount of, for example, about 0.05 to 5% by mass, more preferably about 0.1 to 3% by mass, or about 0.2 to 2% by mass.
The oral composition of the present invention can be produced by a usual method, and can be used as a pharmaceutical product or quasi-pharmaceutical product, for example. Particularly preferred are usual oral compositions or quasi-drugs which can be selected and used by the consumer at the discretion of the consumer. The form of the oral composition of the present invention is not particularly limited, and forms (dosage forms) such as ointments, pastes (pasta), gels (gel) agents, liquids, sprays (spray) agents, mouthwashes, liquid dentifrices, toothpastes, and coating agents may be prepared according to a common method. Among them, a mouthwash, a liquid dentifrice, a toothpaste, a paste, a liquid, a spray, a gel, and a coating agent are preferable, and a toothpaste, a paste, and a gel are more preferable.
In the oral composition of the present invention, in addition to the above-mentioned components (a) to (D), two or more optional components that can be blended in the oral composition may be blended singly or in combination within a range that does not impair the effects of the present invention.
For example, as the surfactant, nonionic surfactant, anionic surfactant, or amphoteric surfactant may be formulated. Specifically, as the nonionic surfactant, there may be exemplified: sugar fatty acid esters such as sucrose fatty acid ester, maltose fatty acid ester and lactose fatty acid ester; fatty acid alkanolamides; sorbitan fatty acid esters; fatty acid monoglycerides; polyoxyethylene alkyl ether with polyoxyethylene addition coefficient of 8-10 and alkyl carbon number of 13-15; polyoxyethylene alkylphenyl ether having a polyoxyethylene addition coefficient of 10 to 18 and an alkyl group having 9 carbon atoms; diethyl sebacate; polyoxyethylene hardened castor oil; fatty acid polyoxyethylene sorbitan, and the like. As the anionic surfactant, there may be exemplified: sulfate salts such as sodium lauryl sulfate and sodium polyoxyethylene lauryl ether sulfate; sodium lauryl sulfosuccinate, sodium polyoxyethylene lauryl ether sulfosuccinate and other sulfosuccinates; acyl amino acid salts such as sodium cocoyl sarcosinate and sodium lauroyl methylalaninate; sodium cocoyl methyl taurate, and the like. As the zwitterionic surfactant, there may be exemplified: acetic acid betaine type active agents such as lauryl dimethyl amino acetic acid betaine and coco fatty acid amidopropyl dimethyl amino acetic acid betaine; imidazoline-type active agents such as N-cocoyl-N-carboxymethyl-N-hydroxyethyl ethylenediamine sodium; amino acid type active agents such as N-lauryldiaminoethylglycine, etc. These surfactants may be formulated singly or in combination of two or more. The amount of the compound is usually 0.1 to 5% by mass based on the total amount of the composition.
Further, sweeteners such as saccharin sodium, acesulfame potassium (acesulfame potassium), stevioside (stevioside), neohesperidin dihydrochalcone (neohesperidin dihydrochalcone), perillartine (perillartine), thaumatin (thaumatin), aspartame (aspartyl phenylalanine methyl ester), and p-methoxycinnamaldehyde may be formulated. These sweeteners may be used singly or in combination of two or more. These sweeteners may be blended in an amount of 0.01 to 1% by mass based on the total amount of the composition.
As the binder, for example, one or a combination of two or more of the following compounds may be used: cellulose derivatives such as sodium carboxymethyl cellulose, carboxymethyl ethyl cellulose salt, hydroxyethyl cellulose, hydroxypropyl cellulose, and hydroxypropyl methyl cellulose; microorganisms such as xanthan gum (xanthan gum) and gellan gum (gellan gum) produce polymers; natural polymers or natural rubbers such as tragacanth gum (tragacanth gum), karaya gum (karaya gum), acacia gum (Arabic gum), carrageenan (carageenan), and dextrin (dextran); synthetic polymers such as polyvinyl alcohol and polyvinylpyrrolidone; inorganic binders such as magnesium aluminum silicate (Veegum); cationic binders such as O- [ 2-hydroxy-3- (trimethylammonio) propyl ] hydroxyethyl cellulose chloride.
As the preservative, two or more of the following compounds may be formulated singly or in combination: parabens such as methyl paraben, ethyl paraben, propyl paraben, and butyl paraben; sodium benzoate, phenoxyethanol, alkyldiaminoethyl glycine hydrochloride, and the like.
As the colorant, two or more of the following compounds may be formulated singly or in combination: legal pigments such as blue No. 1, yellow No. 4, red No. 202, green No. 3, etc.; mineral pigments such as ultramarine, reinforced ultramarine, prussian blue and the like; titanium oxide, and the like.
As the pH adjuster, citric acid, phosphoric acid, malic acid, pyrophosphoric acid, lactic acid, tartaric acid, glycerophosphate, acetic acid, nitric acid, or a chemically realized salt of these compounds, sodium hydroxide, or the like may be formulated. These pH adjusters may be blended singly or in combination so that the pH of the composition is in the range of 4 to 8, preferably 5 to 7. The amount of the pH adjustor can be exemplified by, for example, 0.01 to 2% by weight.
As the effective component, a bactericide may be formulated. Examples include: cationic bactericides such as cetylpyridinium chloride, benzalkonium chloride (benzalkonium chloride), benzethonium chloride (benzethonium chloride), chlorhexidine hydrochloride, chlorhexidine gluconate, and the like; amphoteric bactericides such as dodecyl diamino ethyl glycine; nonionic bactericides such as triclosan (triclosan) and isopropyl methylphenol; hinokitiol (hinokitiol), and the like. Further, other effective components than the bactericide may be blended. For example, vitamin E such as dl-alpha-tocopherol acetate, tocopherol succinate, or tocopherol nicotinate, sodium fluoride, etc. may be blended. The effective components other than bactericide can be blended singly or in combination.
As the base, for example, two or more kinds of water, alcohols, silicone, apatite (apatites), white vaseline, paraffin, liquid paraffin, microcrystalline wax, squalane (squarane), a composite ointment base of liquid paraffin and polyethylene (plasitibase) (manufactured by da positive pharmaceutical company) and the like may be added singly or in combination. However, in the case of using alcohols, special care should be taken not to impair the effect of the present invention.
The above description of any component is illustrative, and any component that can be used is not limited.
The present invention also provides a method for inhibiting yellowing of an oral composition, which comprises a step of blending component (D), wherein the oral composition contains component (a), component (B), and component (C). The present invention also includes a method for producing an oral composition comprising a step of blending component (D), wherein the oral composition contains component (a), component (B), and component (C) and is inhibited from yellowing.
Various preferred embodiments of these methods (for example, the mass ratio of the components (a) to (D) and the amount to be blended) are as described above.
In addition, the term "comprising" as used herein includes "including" and "including" in nature "(The term" including "includes" consisting essentially of "and" including "of." and "including" consisting essentially of "and" including of. ").
Examples (example)
The present invention will be described more specifically below, but the present invention is not limited to the following examples.
Paste compositions (examples, comparative examples, and reference examples) were prepared by mixing the components in accordance with the compositions shown in table 1 by a usual method. The numerical values of the components in table 1 represent parts by mass. Otherwise, example 7 is the same as example 19.
Each 10g of the composition of each example was placed flatly on a glass plate and placed in a glass bottle. The glass bottle was irradiated with artificial light similar to sunlight or fluorescent lamps for 20 hours using a sunlight weather resistant test box (Sunshine Weather Meter). Further, the solar weather resistance test box is a machine for evaluating the resistance to degradation by natural environment in a short time. In this test, carbon arc type, which is a system of irradiating artificial light in an ultraviolet region of sunlight with enhanced intensity, was used.
Then, each composition after artificial light irradiation was collected by 0.1g each and placed on a glass plate, and then sandwiched by another glass plateAnd flattened so that air does not enter. L was measured using a fluorescence spectrometer (FD-5, kenica Minolta Co., ltd.) * a * b * B of the color system * Values. In addition, L * a * b * In the color system, L * Represents brightness, a * Representing the red direction, -a * Represents the green direction, b * Representing the yellow direction, -b * Indicating the blue direction. Said b * The measurement results of the values are also shown in Table 1. Further, whether or not the appearance of each composition was yellowing was visually observed, and the case where no yellowing was evaluated as o, the case where some yellowing was observed as Δ, and the case where yellowing was observed as x. The evaluation is also shown in table 1.
TABLE 1
The following shows formulation examples of the oral composition of the present invention. The following formulation examples were all paste compositions. The blending amount of each component is mass%.
TABLE 2
Formulation example 1
TABLE 3
Formulation example 2
TABLE 4
Formulation example 3
TABLE 5
Formulation example 4
TABLE 6
Formulation example 5
TABLE 7
Formulation example 6
TABLE 8
Formulation example 7
TABLE 9
Formulation example 8
TABLE 10
Formulation example 9
/>
Claims (4)
1. An oral composition comprising:
component A: silica particles;
and the component B comprises the following components: titanium oxide;
and C, component: olive oil; a kind of electronic device with high-pressure air-conditioning system
And D, component: at least one selected from the group consisting of polyethylene glycol, propylene glycol, 1, 3-butanediol, glycerol, diglycerol and sorbitol,
wherein the oral composition does not comprise xylitol,
wherein the D component is 5 to 40% by mass relative to the oral composition,
wherein the mass ratio of the D component to the C component is 1 part by mass of the D component to 6 parts by mass or less of the C component, and the mass ratio of the B component to the C component is 1:0.01 to 1:10,
wherein the C component is 0.005 to 8 mass%.
2. The oral composition of claim 1, which is a dentifrice composition.
3. A method of inhibiting yellowing of an oral composition comprising: and (3) preparing a component D: a step of selecting at least one selected from the group consisting of polyethylene glycol, propylene glycol, 1, 3-butanediol, glycerol, diglycerol and sorbitol, and
the oral composition comprises an ingredient A: silica particles, component B: titanium oxide, and component C: the oil content of the olive oil,
wherein the oral composition does not comprise xylitol,
wherein the D component is 5 to 40% by mass relative to the oral composition,
wherein the mass ratio of the D component to the C component is 1 part by mass of the D component to 6 parts by mass or less of the C component, and the mass ratio of the B component to the C component is 1:0.01 to 1:10,
wherein the C component is 0.005 to 8 mass%.
4. A method of manufacturing an oral composition comprising: and (3) preparing a component D: a step of selecting at least one selected from the group consisting of polyethylene glycol, propylene glycol, 1, 3-butanediol, glycerol, diglycerol and sorbitol, and
the oral composition comprises an ingredient A: silica particles, component B: titanium oxide, and component C: olive oil, and the yellowing of the oral composition is suppressed,
wherein the oral composition does not comprise xylitol,
wherein the D component is 5 to 40% by mass relative to the oral composition,
wherein the mass ratio of the D component to the C component is 1 part by mass of the D component to 6 parts by mass or less of the C component, and the mass ratio of the B component to the C component is 1:0.01 to 1:10,
wherein the C component is 0.005 to 8 mass%.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017-198819 | 2017-10-12 | ||
JP2017198819A JP7368931B2 (en) | 2017-10-12 | 2017-10-12 | Oral composition |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109646315A CN109646315A (en) | 2019-04-19 |
CN109646315B true CN109646315B (en) | 2023-12-29 |
Family
ID=66110032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811182360.2A Active CN109646315B (en) | 2017-10-12 | 2018-10-11 | Oral composition, method for producing same, and method for inhibiting yellowing of oral composition |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP7368931B2 (en) |
CN (1) | CN109646315B (en) |
MY (1) | MY201993A (en) |
TW (1) | TW201914571A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4894220A (en) * | 1987-01-30 | 1990-01-16 | Colgate-Palmolive Company | Antibacterial antiplaque oral composition |
CN1461209A (en) * | 2000-10-16 | 2003-12-10 | 生物化妆品有限公司 | Use of olive oil in preparation of products for oral hygiene for eliminating or reducing bacterial plaque and/or bacteria in mouth |
CN101678217A (en) * | 2007-02-22 | 2010-03-24 | 生技化妆品有限公司 | Composition for treatment of xerostomy or dry mouth |
-
2017
- 2017-10-12 JP JP2017198819A patent/JP7368931B2/en active Active
-
2018
- 2018-10-11 TW TW107135831A patent/TW201914571A/en unknown
- 2018-10-11 CN CN201811182360.2A patent/CN109646315B/en active Active
- 2018-10-12 MY MYPI2018703768A patent/MY201993A/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4894220A (en) * | 1987-01-30 | 1990-01-16 | Colgate-Palmolive Company | Antibacterial antiplaque oral composition |
CN1461209A (en) * | 2000-10-16 | 2003-12-10 | 生物化妆品有限公司 | Use of olive oil in preparation of products for oral hygiene for eliminating or reducing bacterial plaque and/or bacteria in mouth |
CN101678217A (en) * | 2007-02-22 | 2010-03-24 | 生技化妆品有限公司 | Composition for treatment of xerostomy or dry mouth |
Also Published As
Publication number | Publication date |
---|---|
JP2019073452A (en) | 2019-05-16 |
CN109646315A (en) | 2019-04-19 |
TW201914571A (en) | 2019-04-16 |
JP7368931B2 (en) | 2023-10-25 |
MY201993A (en) | 2024-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2013364202B2 (en) | Zinc amino acid halide complex with cysteine | |
EP1904025B1 (en) | Oral composition containing non-aggregated zinc nanoparticles | |
CN102821739B (en) | Oral care composition | |
EP2648679B1 (en) | Dentifrice compositions containing calcium silicate and a basic amino acid | |
EP2648677B1 (en) | Dentifrice compositions containing calcium silicate | |
EP2555829B1 (en) | Oral care compositions | |
AU2011383731B2 (en) | Oral care compositions | |
US10576033B2 (en) | Dentifrice comprising zinc-amino acid complex | |
NZ246184A (en) | Dentifrice comprising a lanthocin antibacterial agent | |
AU2016256382B2 (en) | Oral care compositions | |
JP6125859B2 (en) | Composition for external use | |
BR112017023476B1 (en) | APPLICATION DEVICE TO DISTRIBUTE AN ENAMEL REGENERATION SYSTEM TO DENTAL SURFACES | |
EP2694020B1 (en) | Oral care compositions | |
CN109646315B (en) | Oral composition, method for producing same, and method for inhibiting yellowing of oral composition | |
BR112017023494B1 (en) | distribution system to distribute an enamel regeneration system | |
EP2275084A1 (en) | Oral care composition | |
JP7146389B2 (en) | oral composition | |
JP2012106941A (en) | Aqueous composition and optical stabilization method of vitamin b6 in the aqueous composition | |
DE102012220154A1 (en) | Oral and dental care and cleanser with vitamin E | |
CN108685742B (en) | Low irritation oral compositions | |
CA3224796A1 (en) | Oral care compositions comprising hydroxyapatite | |
CN116981440A (en) | Oral care compositions | |
AU2003204913B2 (en) | Cyclodextrins in Dental Products | |
KR20190076829A (en) | Oral composition and method for inhibiting discoloration thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |